Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Tongue scraping may freshen breath in gum disease patients

NCT ID NCT06091228

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether adding tongue scraping to standard gum disease treatment can improve bad breath. About 39 adults with gum disease and bad breath will either get standard care or standard care plus twice-daily tongue scraping. Researchers will measure breath odor and sulfur compounds to see if the tongue scraper makes a difference.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
tongue scraper
What this could lead to
If it works, this could point toward a simple, low-cost addition to gum disease treatment that helps reduce bad breath.
What could go wrong
This is a small, early-stage study with only 39 participants, so results may not apply to everyone. Tongue scraping is generally safe but may cause gagging or irritation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 39 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2024

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Voluntary written informed consent of the participant or their legally authorized representative has been obtained prior to any screening procedures * Males or females American Society of Anesthesiologist classification I of II, * 18 years of age or older, * In good general health as documented by self-assessment * Suffer from generalised periodontitis (according to 2018 classification) * Suffer from halitosis with suspected intra-oral cause: organoleptic score (OLS) of 2 or higher by an experienced oral malodour judge * At least one volatile sulphur compounds(VSCs) measurement above the following thresholds: 1. Portable sulphur detector (Halimeter) \> 107 ppb 2. Oral Chroma™: hydrogen sulfide (H₂S) \> 112ppb 3. Oral Chroma™: methyl mercaptan (CH3SH) \>28ppb Exclusion Criteria: * Participant has a history of chemotherapy or radiotherapy in head and neck area * Any disorder, which in the Investigator's opinion might jeopardise the participant's safety or compliance with the protocol * Any prior or concomitant treatment(s) that might jeopardise the participant's safety or that would compromise the integrity of the Trial * Female who is pregnant, breast-feeding or has the intention of becoming pregnant in the following 6 months * Participation in another interventional Trial with an investigational medicinal product (IMP) or device * Recent intake of antibiotics (3 months prior to the first consultation) * Antibiotics indicated as part of the periodontal treatment * Use of antibiotics during the course of the study * Suffer from halitosis with suspected extra-oral cause * Suffer from a systemic disease that could cause extra-oral halitosis (e.g. diabetes mellitus, liver or kidney failure, trimethylaminuria) * Participant has a history of rheumatic fever, neurological deficiencies, or use of medication which may affect periodontal tissue, (phenytoin, cyclosporin, nifedipine, chronic use of non-steroidal anti-inflammatory drugs) * Presence of active caries lesions * Unwillingness to return for the follow-up examination * Wear partial prosthetic dentures removables * Participant has less than 20 teeth

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Halitosis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • UZLeuven, Campus SintRafael

    RECRUITING

    Leuven, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.